Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Clinical Genomics Laboratory
Explore this Website
Home
About Us
Toggle About Us menu options
Faculty Directory
News & Updates
Publications
Testing Portfolio
Toggle Testing Portfolio menu options
My Heme Panel
Oncomine
Oncomine Comprehensive Assay v2
TruSight Oncology 500 Assay
Ordering a Test
Toggle Ordering a Test menu options
For WCM/NYP Physicians
For External Physicians
Financial Services
Your Privacy
Contact Us
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Testing Portfolio
Ordering a Test
Financial Services
Your Privacy
Contact Us
Home
Publications
Publications
Faculty Directory
News & Updates
Publications
Publications
Found 6 results
Author
Title
Type
[
Year
]
Filters:
First Letter Of Last Name
is
Z
[Clear All Filters]
2019
Schwartz GW, Manning B, Zhou Y, Velu P, Bigdeli A, Astles R, Lehman AW, Morrissette JJD, Perl AE, Li M et al.
. 2019.
Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 Inhibitors.
.
Clin Cancer Res. 25(2):573-583.
Sailer V, Eng KWa, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
2017
Huang L, Fernandes H, Zia H, Tavassoli P, Rennert H, Pisapia D, Imielinski M, Sboner A, Rubin MA, Kluk M et al.
. 2017.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations.
.
J Am Med Inform Assoc. 24(3):513-519.
Saab J, Zia H, Mathew S, Kluk M, Narula N, Fernandes H
. 2017.
Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.
.
Transl Oncol. 10(3):442-449.
2016
Rennert H, Eng K, Zhang T, Tan A, Xiang J, Romanel A, Kim R, Tam W, Liu Y-C, Bhinder B et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
2015
Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, Chandramohan R, Liu ZYu, Won HH, Scott SN et al.
. 2015.
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
.
J Mol Diagn. 17(3):251-64.